Literature DB >> 28321676

Transdermal delivery of human growth hormone via laser-generated micropores.

Yang Song1, Karishma Hemmady2, Ashana Puri1, Ajay K Banga3.   

Abstract

The epidermal skin barrier plays an important role in protecting underlying structures. It allows the passage of low molecular weight lipophilic molecules, but restricts the passage of hydrophilic molecules and macromolecules. The objective of this study was to investigate the feasibility of transdermal delivery of human growth hormone (hGH) through laser-microporated dermatomed porcine ear skin. The permeation of hGH was evaluated at different laser fluences and micropore densities. In vitro permeation studies were performed on vertical Franz diffusion cells using dermatomed porcine ear skin treated with ablative laser (2940 nm; P.L.E.A.S.E®, Pantec Biosolutions AG). The effect of different fluences (34.1, 45.4, and 68.1 J/cm2) at 10% pore density as well as different densities of micropores (5, 10, and 15%) at fluence of 34.1 J/cm2, on the permeation of hGH was evaluated. After 48 h, 77.12 ± 10.77 μg/cm2 hGH was delivered into the receptor with the application of fluence of 45.4 J/cm2, which was significantly higher than that observed from 34.1 J/cm2 group (53.13 ± 1.75 μg/cm2, p < 0.05). Application of fluence of 68.1 J/cm2 showed permeation of 90.94 ± 3.93 μg/cm2 that was significantly higher than that from 34.1 J/cm2 group (p < 0.05), but not as compared to the 45.4 J/cm2 group (p > 0.05). With the increase in density of micropores from 5 to 15%, permeation of hGH increased significantly from 7.1 ± 2.63 μg/cm2 to 95.89 ± 13.43 μg/cm2 after 48 h (p < 0.05). Thus, overall, the variations in the fluence as well as micropore density of the laser were observed to influence hGH permeation, through laser-microporated dermatomed porcine skin.

Entities:  

Keywords:  Ablative laser; Human growth hormone; Macromolecule; Skin permeation; Transdermal delivery

Mesh:

Substances:

Year:  2018        PMID: 28321676     DOI: 10.1007/s13346-017-0370-y

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   4.617


  28 in total

1.  Can fractional lasers enhance transdermal absorption of topical lidocaine in an in vivo animal model?

Authors:  Georgette Oni; Spencer A Brown; Jeffrey M Kenkel
Journal:  Lasers Surg Med       Date:  2012-02-02       Impact factor: 4.025

2.  Enhanced skin delivery of vismodegib by microneedle treatment.

Authors:  Hiep X Nguyen; Ajay K Banga
Journal:  Drug Deliv Transl Res       Date:  2015-08       Impact factor: 4.617

3.  Facilitation of transcutaneous drug delivery and vaccine immunization by a safe laser technology.

Authors:  Xinyuan Chen; Dilip Shah; Garuna Kositratna; Dieter Manstein; Richard R Anderson; Mei X Wu
Journal:  J Control Release       Date:  2012-01-09       Impact factor: 9.776

4.  A comparison of subcutaneous and intramuscular administration of human growth hormone (hGH) and increased growth rate by daily injection of hGH in GH deficient children.

Authors:  K Takano; K Shizume; I Hibi
Journal:  Endocrinol Jpn       Date:  1988-06

5.  Laser-assisted intradermal delivery of adjuvant-free vaccines targeting XCR1+ dendritic cells induces potent antitumoral responses.

Authors:  Dorothea Terhorst; Even Fossum; Anna Baranska; Samira Tamoutounour; Camille Malosse; Mattia Garbani; Reinhard Braun; Elmira Lechat; Reto Crameri; Bjarne Bogen; Sandrine Henri; Bernard Malissen
Journal:  J Immunol       Date:  2015-05-04       Impact factor: 5.422

6.  Favourable dermal penetration of diclofenac after administration to the skin using a novel spray gel formulation.

Authors:  Martin Brunner; Pejman Dehghanyar; Bernd Seigfried; Wolfgang Martin; Georg Menke; Markus Müller
Journal:  Br J Clin Pharmacol       Date:  2005-11       Impact factor: 4.335

Review 7.  Human growth hormone.

Authors:  J S Strobl; M J Thomas
Journal:  Pharmacol Rev       Date:  1994-03       Impact factor: 25.468

8.  Microneedle-mediated intradermal delivery of epigallocatechin-3-gallate.

Authors:  A Puri; H X Nguyen; A K Banga
Journal:  Int J Cosmet Sci       Date:  2016-04-22       Impact factor: 2.970

9.  Transcutaneous vaccination via laser microporation.

Authors:  Richard Weiss; Michael Hessenberger; Sophie Kitzmüller; Doris Bach; Esther E Weinberger; Wolf D Krautgartner; Cornelia Hauser-Kronberger; Bernard Malissen; Christof Boehler; Yogeshvar N Kalia; Josef Thalhamer; Sandra Scheiblhofer
Journal:  J Control Release       Date:  2012-06-29       Impact factor: 9.776

Review 10.  Growth hormone and aging: a challenging controversy.

Authors:  Andrzej Bartke
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

View more
  5 in total

1.  Novel drug delivery systems, devices, and fabrication methods.

Authors:  Vivek Agrahari
Journal:  Drug Deliv Transl Res       Date:  2018-04       Impact factor: 4.617

2.  mPEG-PLA and PLA-PEG-PLA nanoparticles as new carriers for delivery of recombinant human Growth Hormone (rhGH).

Authors:  Rohollah Ghasemi; Mahdi Abdollahi; Elaheh Emamgholi Zadeh; Khosrow Khodabakhshi; Ali Badeli; Hamed Bagheri; Saman Hosseinkhani
Journal:  Sci Rep       Date:  2018-06-29       Impact factor: 4.379

Review 3.  Enhancing Permeation of Drug Molecules Across the Skin via Delivery in Nanocarriers: Novel Strategies for Effective Transdermal Applications.

Authors:  Yi-Qun Yu; Xue Yang; Xiao-Fang Wu; Yi-Bin Fan
Journal:  Front Bioeng Biotechnol       Date:  2021-03-29

4.  Fractional laser ablation for the targeted cutaneous delivery of an anti-CD29 monoclonal antibody - OS2966.

Authors:  Maria Lapteva; Sergio Del Río-Sancho; Eric Wu; W Shawn Carbonell; Christof Böhler; Yogeshvar N Kalia
Journal:  Sci Rep       Date:  2019-01-31       Impact factor: 4.379

5.  Effect of mRNA Delivery Modality and Formulation on Cutaneous mRNA Distribution and Downstream eGFP Expression.

Authors:  Aditya R Darade; Maria Lapteva; Thomas Hoffmann; Markus Mandler; Achim Schneeberger; Yogeshvar N Kalia
Journal:  Pharmaceutics       Date:  2022-01-08       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.